S

SynAct Pharma AB
STO:SYNACT

Watchlist Manager
SynAct Pharma AB
STO:SYNACT
Watchlist
Price: 19.96 SEK
Market Cap: 978.2m SEK

Operating Margin
SynAct Pharma AB

0%
Current
0%
Average
-5.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-92.4m
/
Revenue
0

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
SE
SynAct Pharma AB
STO:SYNACT
978.2m SEK N/A
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
337.9B USD
30%
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD
-2 834%
US
Amgen Inc
NASDAQ:AMGN
165.8B USD
25%
US
Gilead Sciences Inc
NASDAQ:GILD
141.4B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.6B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
130.4B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.9B USD
29%
US
Seagen Inc
F:SGT
39.3B EUR
-33%

SynAct Pharma AB
Glance View

Market Cap
978.2m SEK
Industry
Biotechnology

SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. The company is headquartered in Lund, Skane. The company went IPO on 2016-07-11. The firm is located in Lund, Sweden. The company develops medicines for acute impairment in inflammatory diseases. The firm's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

SYNACT Intrinsic Value
48.28 SEK
Undervaluation 59%
Intrinsic Value
Price
S
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-92.4m
/
Revenue
0
What is the Operating Margin of SynAct Pharma AB?

Based on SynAct Pharma AB's most recent financial statements, the company has Operating Margin of 0%.

Back to Top